Adaptation of Impression Cytology to Enable Conjunctival Surface Cell Transcriptome Analysis

References

• Lemp MA, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, Laibson P, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). The Ocular Surface 2007;5:75–92
   Google Scholar
• Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009;3:405–412
   PubMedGoogle Scholar
• Levin LA, Kaufman PL. Adler's physiology of the eye: clinical application. 11th ed. Edinburgh, New York: Saunders/Elsevier; 2011. pp. xii, 795
   Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–558
   PubMed Web of Science ®Google Scholar
• Bowman SJ. Biologic therapies in primary Sjogren's syndrome. Curr Pharma Biotechnol 2012;13:1997–2008
   Google Scholar
• Cho P, Yap M. Schirmer test. I. A review. Optometry Vis Sci: Off Publ Am Acad Optometry 1993;70:152–156
   PubMed Web of Science ®Google Scholar
• Korb DR, Herman JP, Finnemore VM, Exford JM, Blackie CA. An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining. Eye & Contact Lens 2008;34:61–64
   PubMed Web of Science ®Google Scholar
• Kim J, Foulks GN. Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells. Cornea 1999;18:328–332
   PubMed Web of Science ®Google Scholar
• Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 2012; DOI:10.1111
   Google Scholar
• Szalai E, Berta A, Szekanecz Z, Szucs G, Modis Jr L. Evaluation of tear osmolarity in non-Sjogren and Sjogren syndrome dry eye patients with the TearLab system. Cornea 2012;31:867–871
   PubMed Web of Science ®Google Scholar
• Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, et al. An objective approach to dry eye disease severity. Investigat Ophthalmol Visual Sci 2010;51:6125–6130
   PubMed Web of Science ®Google Scholar
• LaFrance MW, Kehinde LE, Fullard RJ. Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay. Curr Eye Res 2008;33:525–544
   PubMed Web of Science ®Google Scholar
• Watson SL, Daniels JT, Geerling G, Dart JK. Clinical trials of therapeutic ocular surface medium for moderate to severe dry eye. Cornea 2010;29:1241–1246
   Google Scholar
• Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201–211
   PubMed Web of Science ®Google Scholar
• Burton MJ, Bailey RL, Jeffries D, Rajak SN, Adegbola RA, Sillah A, et al. Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Investigat Ophthalmol Vis Sci 2010;51:3583–3590
   Google Scholar
• Guyette N, Williams L, Tran MT, Than T, Bradley J, Kehinde L, et al. Comparison of low abundance biomarker levels in capillary-collected non-stimulated tears and washout tears of aqueous-deficient and normal patients. Investigat Ophthalmol Vis Sci 2013;54:3729--3737
   Google Scholar
• Applied Biosystems, Inc. TaqMan Array Microfluidic Cards User Guide. Part Number 4400263 Rev. B. Carlsbad, CA: Applied Biosystems, 2010
   Google Scholar
• De Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002;3:0034.1--0034.11
   Google Scholar
• Array-based GENE EXPRESSION ANALYSIS. San Diego, CA: Illumina, Inc.; 2011
   Google Scholar
• Nakken B, Jonsson R, Brokstad KA, Omholt K, Nerland AH, Haga HJ, et al. Associations of MHC class II alleles in Norwegian primary Sjogren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 2001;54:428–433
   PubMedGoogle Scholar
• Lessard CJ, Ice JA, Adrianto I, Kelly JA, Jonsson R, Illei GG, editors. A high-density genome-wide study by the Sjogren's Genetics Network identifies five novel suspectibility loci for priamkry Sjogren's syndrome and confirms MHRC, IRF5 and BLK. ACR/AHRP Annual Meeting; 2011; Chicago
   Google Scholar
• Caffery B, Joyce E, Boone A, Slomovic A, Simpson T, Jones L, et al. Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optometry Vis Sci: Off Publ Am Acad Optometry 2008;85:661–667
   PubMed Web of Science ®Google Scholar
• Versura P, Nanni P, Bavelloni A, Blalock WL, Piazzi M, Roda A, et al. Tear proteomics in evaporative dry eye disease. Eye 2010;24:1396–1402
   PubMed Web of Science ®Google Scholar
• Linge HM, Collin M, Nordenfelt P, Morgelin M, Malmsten M, Egesten A. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob Agents Chemother 2008;52:2599–2607
   PubMed Web of Science ®Google Scholar
• Traves SL, Donnelly LE. Th17 cells in airway diseases. Curr Molec Med 2008;8:416–426
   PubMed Web of Science ®Google Scholar
• Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, Kouriba B, et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 2009;119:2379–2387
   Google Scholar
• Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Ohnogi Y, et al. The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand. Int J Immunogenet 2013;40:126–130
   Google Scholar
• Odani T, Yasuda S, Ota Y, Fujieda Y, Kon Y, Horita T, et al. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. Rheumatology 2012;51:1765–1774
   Web of Science ®Google Scholar
• Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M, et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol 2005;25:6964–6979
   PubMed Web of Science ®Google Scholar
• Kawasaki S, Kawamoto S, Yokoi N, Connon C, Minesaki Y, Kinoshita S, et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sjogren's syndrome. Exp Eye Res 2003;77:17–26
   Google Scholar
• Zatz M, Starling A. Calpains and disease. New Engl J Med 2005;352:2413–2423
   PubMed Web of Science ®Google Scholar
• Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome. Am J Pathol 2005;167:1051–1059
   Google Scholar
• Wente MN, Jain A, Kono E, Berberat PO, Giese T, Reber HA, et al. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer. Pancreas 2005;31:119–125
   PubMed Web of Science ®Google Scholar
• Saeki N, Gu J, Yoshida T, Wu X. Prostate stem cell antigen: a Jekyll and Hyde molecule? Clin Cancer Res: Off J Am Assoc Cancer Res 2010;16:3533–3538
   PubMed Web of Science ®Google Scholar
• Zhigang Z, Wenlv S. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer. Japanese J Clin Oncol 2004;34:414–419
   PubMed Web of Science ®Google Scholar
• Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008;126:219–225
   PubMedGoogle Scholar
• Kawamata H, Fujimori T, Imai Y. TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer. Curr Cancer Drug Targets 2004;4:521–529
   PubMedGoogle Scholar
• Hayashi T. Dysfunction of lacrimal and salivary glands in Sjogren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model. J Biomed Biotechnol 2011;2011:4070312 . doi:10.1155
   Google Scholar